Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.38USD
18 Apr 2019
Change (% chg)

$0.02 (+0.60%)
Prev Close
$3.36
Open
$3.35
Day's High
$3.38
Day's Low
$3.31
Volume
176,397
Avg. Vol
361,809
52-wk High
$5.05
52-wk Low
$2.00

About

AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product... (more)

Overall

Beta: 3.03
Market Cap(Mil.): $231.44
Shares Outstanding(Mil.): 45.38
Dividend: --
Yield (%): --

Financials

  ACRX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.10 -- --
ROI: -63.23 8.91 13.83
ROE: -- 10.06 15.25

FDA approves AcelRx Pharma's opioid pain drug

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

02 Nov 2018

UPDATE 2-U.S. FDA approves AcelRx Pharma's opioid pain drug

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

02 Nov 2018

AcelRx Pharma's opioid pain drug gets U.S. FDA nod

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based pain treatment, a fast-acting pill.

02 Nov 2018

Earnings vs. Estimates